rabeprazole has been researched along with lafutidine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikawa, K; Morikawa, O; Nishina, K; Obara, H; Takao, Y; Uesugi, T | 1 |
| Abe, Y; Chiguchi, G; Inamori, M; Iwasaki, T; Kawamura, H; Kikuchi, T; Kirikoshi, H; Kobayashi, N; Kubota, K; Matsumoto, S; Muramatsu, K; Nakajima, A; Ozawa, Y; Saito, S; Sakaguchi, T; Shimamura, T; Togawa, J; Ueno, N | 1 |
| Kawano, S; Tsuji, S | 1 |
| Asaoka, D; Hojo, M; Ishikawa, D; Kawabe, M; Nagahara, A; Oguro, M; Osada, T; Otaka, M; Shimada, Y; Watanabe, S; Yoshizawa, T | 1 |
| Ando, T; Fujinami, H; Hosokawa, A; Kudo, T; Murakami, J; Nishikawa, J; Ogawa, K; Orihara, T; Sugiyama, T; Takahara, T | 1 |
| Kawashima, M; Murata, T; Terayama, Y | 1 |
3 trial(s) available for rabeprazole and lafutidine
| Article | Year |
|---|---|
The efficacy of lafutidine in improving preoperative gastric fluid property: a comparison with ranitidine and rabeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Female; Gastric Acid; Gastric Acidity Determination; Histamine H2 Antagonists; Humans; Intraoperative Complications; Intubation, Gastrointestinal; Male; Middle Aged; Omeprazole; Piperidines; Preoperative Care; Proton Pump Inhibitors; Pyridines; Rabeprazole; Ranitidine; Risk Assessment; Stomach | 2002 |
Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Administration, Oral; Adult; Benzimidazoles; Cross-Over Studies; Drug Administration Schedule; Gastric Acid; Gastric Acidity Determination; Heartburn; Humans; Hydrogen-Ion Concentration; Male; Monitoring, Physiologic; Omeprazole; Piperidines; Postprandial Period; Pyridines; Rabeprazole; Reference Values; Risk Assessment; Time Factors; Treatment Outcome | 2005 |
Comparison of lafutidine and rabeprazole in 7-day second-line amoxicillin- and metronidazole-containing triple therapy for Helicobacter pylori: a pilot study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pilot Projects; Piperidines; Pyridines; Rabeprazole; Time Factors; Young Adult | 2012 |
3 other study(ies) available for rabeprazole and lafutidine
| Article | Year |
|---|---|
A new-generation H2 receptor antagonist: quicker and stronger acid inhibition than proton pump inhibitors in the clinical setting?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Benzimidazoles; Gastric Acid; Gastric Acidity Determination; Heartburn; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Omeprazole; Piperidines; Prognosis; Proton Pump Inhibitors; Pyridines; Rabeprazole; Severity of Illness Index; Treatment Outcome | 2005 |
Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Dyspepsia; Esophageal Motility Disorders; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Japan; Male; Middle Aged; Pain; Pain Measurement; Piperidines; Proton Pump Inhibitors; Pyridines; Rabeprazole; Retrospective Studies; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2010 |
[Case report: patient with central nervous system side effects due to lafutidine].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Anti-Ulcer Agents; Central Nervous System Diseases; Clopidogrel; Histamine H2 Antagonists; Humans; Middle Aged; Piperidines; Pyridines; Rabeprazole; Stomach Ulcer; Ticlopidine | 2012 |